DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2258521/t-rowe-price-trow-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2258521 Apr 19, 2024 - T. Rowe (TROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0

https://www.fool.com/investing/2024/04/19/3-top-tech-stocks-to-buy-in-april/?source=iedfolrf0000001 Apr 19, 2024 - AT&T, TSMC, and Palo Alto Networks could head higher throughout the rest of the year. 0

https://www.zacks.com/stock/news/2258355/at-t-t-q1-earnings-on-the-horizon-analysts-insights-on-key-performance-measures?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2258355 Apr 19, 2024 - Beyond analysts' top -and-bottom-line estimates for AT&T (T), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024. 0

https://seekingalpha.com/article/4683831-m-and-t-bank-corporation-mtb-q1-2024-earnings-call-transcript?source=feed_sector_transcripts Apr 15, 2024 - M&T Bank Corporation (NYSE:NYSE:MTB) Q1 2024 Earnings Call Transcript April 15, 2024 8:00 AM ETCompany ParticipantsBrian Klock - Investor RelationsDaryl... 0

https://www.zacks.com/stock/news/2255223/m-t-bank-mtb-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2255223 Apr 15, 2024 - The headline numbers for M&T Bank (MTB) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. 0

https://www.zacks.com/stock/news/2254046/t-rowe-trow-upgraded-to-strong-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2254046 Apr 11, 2024 - T. Rowe (TROW) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. 0

https://www.zacks.com/stock/news/2254012/what-s-in-the-offing-for-m-t-bank-mtb-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2254012 Apr 11, 2024 - Despite a rise in loans, increasing funding costs are likely to have hurt M&T Bank's (MTB) Q1 NII growth. Also, softer mortgage income is expected to have affected its non-interest income. 0

https://www.boston.com/cars/national-news/2024/04/10/ford-recalls-nearly-43000-suvs-due-to-gas-leaks-that-can-cause-fires-but-remedy-wont-fix-leaks/ Apr 10, 2024 -

Ford is recalling nearly 43,000 small SUVs because gasoline can leak from the fuel injectors onto hot engine surfaces, increasing the risk of fires

The post Ford recalls nearly 43,000 SUVs due to gas leaks that can cause fires, but remedy won’t fix leaks appeared first on Boston.com.

0

https://www.zacks.com/stock/news/2253218/unveiling-m-t-bank-mtb-q1-outlook-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2253218 Apr 10, 2024 - Get a deeper insight into the potential performance of M&T Bank (MTB) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. 0

https://www.zacks.com/stock/news/2252179/bristol-myers-bmy-gets-fda-nod-for-label-expansion-of-abecma?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2252179 Apr 08, 2024 - Bristol Myers (BMY) wins FDA approval for CAR T cell immunotherapy, Abecma, in earlier lines of treatment for patients with relapsed or refractory multiple myeloma. 0